Genomic technologies, such as next-generation sequencing (NGS), have opened new avenues for understanding the genetic basis of diseases. These technologies enable the identification of genetic mutations and variants associated with diseases, facilitating personalized medicine and targeted therapies. In epidemiology, genomic data can help trace the origin and spread of infectious diseases, providing insights into pathogen evolution and resistance.
